Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists (Q37020195)

17 August 2017

title

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists (English)

1 reference

17 August 2017

1 reference

Collins P

1

1 reference

17 August 2017

Rosano G

2

1 reference

17 August 2017

Casey C

3

1 reference

17 August 2017

Daly C

4

1 reference

17 August 2017

Gambacciani M

5

1 reference

17 August 2017

Hadji P

6

1 reference

17 August 2017

Kaaja R

7

1 reference

17 August 2017

Mikkola T

8

1 reference

17 August 2017

Palacios S

9

1 reference

17 August 2017

Preston R

10

1 reference

17 August 2017

Simon T

11

1 reference

17 August 2017

Stevenson J

12

1 reference

17 August 2017

Stramba-Badiale M

13

1 reference

17 August 2017

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

10

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

508-526

1 reference

Gender and the treatment of heart disease in older persons in the United States, France, and England: a comparative, population-based view of a clinical phenomenon

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Why a consensus conference on hormone replacement therapy and the cardiovascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Angina with "normal" coronary arteries: a changing philosophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Estrogen deprivation, rather than age, is responsible for the poor lipid profile and carbohydrate metabolism in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Global burden of hypertension: analysis of worldwide data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Smoking and risk of myocardial infarction in women and men: longitudinal population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Combined oral contraceptives and the risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Diabetes prevalence in England, 2001--estimates from an epidemiological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Predictors of postpartum diabetes in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Insulin resistance and sympathetic overactivity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Is there any link between insulin resistance and inflammation in established preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Assessment of quality of life with the Nottingham Health Profile among women with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Life expectancy: women now on top everywhere

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Hormonal changes in the menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The menopause transition: endocrine changes and clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Sex, hormones, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Hot flashes: phenomenology, quality of life, and search for treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Menopausal symptoms in older women and the effects of treatment with hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

'Menopausal symptoms': associations with menopausal status and psychosocial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Short-term menopausal hormone therapy for symptom relief: an updated decision model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The ECOS-16 questionnaire for the evaluation of health related quality of life in post-menopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Menopause and risk of cardiovascular disease: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Physiological and metabolic consequences of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Breast cancer risk in the WHI study: the problem of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Estrogen plus progestin and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Estrogen plus progestin and risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Inequity in recording of risk in a local population-based screening programme for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Coronary heart disease prevention: insights from modelling incremental cost effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Incidence and prognostic implications of stable angina pectoris among women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Accuracy of the pressure scale of sphygmomanometers in clinical use within primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Management of prehypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Novel mechanisms responsible for postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Ventricular arterial stiffening: integrating the pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Protective effect of the inhibition of the renin-angiotensin system on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Aldosterone and vascular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Review of aldosterone- and angiotensin II-induced target organ damage and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Drospirenone: pharmacology and pharmacokinetics of a unique progestogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Selection of antihypertensive agents in patients at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

RAS inhibition in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Gender differences in the management and clinical outcome of stable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

The roles of gender, the menopause and hormone replacement on cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Adiposity as Compared with Physical Activity in Predicting Mortality among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Risk for subsequent coronary artery disease after preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

Impact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701755213

10.1080/13697130701755213

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference